110 related articles for article (PubMed ID: 14505089)
1. Expression of Human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi.
Varsani A; Williamson AL; Rose RC; Jaffer M; Rybicki EP
Arch Virol; 2003 Sep; 148(9):1771-86. PubMed ID: 14505089
[TBL] [Abstract][Full Text] [Related]
2. Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum.
Kohl TO; Hitzeroth II; Christensen ND; Rybicki EP
BMC Biotechnol; 2007 Sep; 7():56. PubMed ID: 17850660
[TBL] [Abstract][Full Text] [Related]
3. Transient expression of Human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector.
Varsani A; Williamson AL; Stewart D; Rybicki EP
Virus Res; 2006 Sep; 120(1-2):91-6. PubMed ID: 16530873
[TBL] [Abstract][Full Text] [Related]
4. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
5. Production of human papillomavirus type 16 virus-like particles in transgenic plants.
Biemelt S; Sonnewald U; Galmbacher P; Willmitzer L; Müller M
J Virol; 2003 Sep; 77(17):9211-20. PubMed ID: 12915537
[TBL] [Abstract][Full Text] [Related]
6. Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants.
Liu HL; Li WS; Lei T; Zheng J; Zhang Z; Yan XF; Wang ZZ; Wang YL; Si LS
Acta Biochim Biophys Sin (Shanghai); 2005 Mar; 37(3):153-8. PubMed ID: 15756416
[TBL] [Abstract][Full Text] [Related]
7. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.
Christensen ND; Cladel NM; Reed CA; Budgeon LR; Embers ME; Skulsky DM; McClements WL; Ludmerer SW; Jansen KU
Virology; 2001 Dec; 291(2):324-34. PubMed ID: 11878901
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic.
Fernández-San Millán A; Ortigosa SM; Hervás-Stubbs S; Corral-Martínez P; Seguí-Simarro JM; Gaétan J; Coursaget P; Veramendi J
Plant Biotechnol J; 2008 Jun; 6(5):427-41. PubMed ID: 18422886
[TBL] [Abstract][Full Text] [Related]
9. A deletion and point mutation study of the human papillomavirus type 16 major capsid gene.
Varsani A; Williamson AL; Jaffer MA; Rybicki EP
Virus Res; 2006 Dec; 122(1-2):154-63. PubMed ID: 16938363
[TBL] [Abstract][Full Text] [Related]
10. Self-Assembling Plant-Derived Vaccines Against Papillomaviruses.
Noris E
Methods Mol Biol; 2018; 1776():85-95. PubMed ID: 29869236
[TBL] [Abstract][Full Text] [Related]
11. Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
Pinto LA; Viscidi R; Harro CD; Kemp TJ; García-Piñeres AJ; Trivett M; Demuth F; Lowy DR; Schiller JT; Berzofsky JA; Hildesheim A
Virology; 2006 Sep; 353(2):451-62. PubMed ID: 16863657
[TBL] [Abstract][Full Text] [Related]
12. Viable adenovirus vaccine prototypes: high-level production of a papillomavirus capsid antigen from the major late transcriptional unit.
Berg M; Difatta J; Hoiczyk E; Schlegel R; Ketner G
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4590-5. PubMed ID: 15767581
[TBL] [Abstract][Full Text] [Related]
13. Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1.
Baud D; Ponci F; Bobst M; De Grandi P; Nardelli-Haefliger D
J Virol; 2004 Dec; 78(23):12901-9. PubMed ID: 15542642
[TBL] [Abstract][Full Text] [Related]
14. Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development.
Khanal S; Ferraris ED; Zahin M; Joh J; Ghim SJ; Jenson AB
Exp Mol Pathol; 2015 Oct; 99(2):330-4. PubMed ID: 26134615
[TBL] [Abstract][Full Text] [Related]
15. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
Kirnbauer R; Booy F; Cheng N; Lowy DR; Schiller JT
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12180-4. PubMed ID: 1334560
[TBL] [Abstract][Full Text] [Related]
16. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.
Park JS; Oh YK; Kang MJ; Kim CK
J Med Virol; 2003 Aug; 70(4):633-41. PubMed ID: 12794729
[TBL] [Abstract][Full Text] [Related]
17. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
[TBL] [Abstract][Full Text] [Related]
18. Oral immunogenicity of human papillomavirus-like particles expressed in potato.
Warzecha H; Mason HS; Lane C; Tryggvesson A; Rybicki E; Williamson AL; Clements JD; Rose RC
J Virol; 2003 Aug; 77(16):8702-11. PubMed ID: 12885889
[TBL] [Abstract][Full Text] [Related]
19. Mutant canine oral papillomavirus L1 capsid proteins which form virus-like particles but lack native conformational epitopes.
Chen Y; Ghim SJ; Jenson AB; Schlegel R
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2137-46. PubMed ID: 9747722
[TBL] [Abstract][Full Text] [Related]
20. Efficiency of HPV 16 L1/E7 DNA immunization: influence of cellular localization and capsid assembly.
Kuck D; Leder C; Kern A; Müller M; Piuko K; Gissmann L; Kleinschmidt JA
Vaccine; 2006 Apr; 24(15):2952-65. PubMed ID: 16414157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
